Attitude and efficacy of cardiologists with respect to smoking in patients after acute coronary syndromes;Actitud y eficacia de los cardiólogos frente al tabaquismo de los pacientes tras un síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 65, Issue 8, 2012, Pages 719-725

  Cordero, Alberto ^a   Bertomeu Martínez, Vicente ^a   Mazón, Pilar ^b   Cosín, Juan ^c   Galve, Enrique ^d   Lekuona, Iñaki ^e   De La Guía, Fernando ^f   Gonzalez Juanatey, José Ramón ^b  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL DE GALDAKAO   (Spain)

^f HOSPITAL MARINA BAIXA   (Spain)

Author keywords

Abstinence; Acute coronary syndromes; Smoking; Smoking cessation support

Indexed keywords

VARENICLINE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOLOGIST; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PHYSICIAN ATTITUDE; PROSPECTIVE STUDY; SMOKING; SMOKING CESSATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION; SPAIN;

EID: 84864148527     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.03.012     Document Type: Article

References (31)

1. K.K. Teo, S. Ounpuu, S. Hawken, M.R. Pandey, V. Valentin, and D. Hunt Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study Lancet 368 2006 647 658
2. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cunat, E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) Resultados globales Rev Esp Cardiol 61 2008 803 816
3. V. Bertomeu, P. Morillas, J.R. Gonzalez-Juanatey, J. Quiles, J. Guindo, and F. Soria Prevalence and prognostic influence of peripheral arterial disease in patients ≥40 years old admitted into hospital following an acute coronary event Eur J Vasc Endovasc Surg 36 2008 189 196
4. L. Bjorck, A. Rosengren, L. Wallentin, and U. Stenestrand Smoking in relation to ST-segment elevation acute myocardial infarction: findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions Heart 95 2009 1006 1011
5. P. Palau, J. Núñez, J. Sanchís, V. Bodí, E. Rumiz, and E. Núñez Impacto pronóstico de una estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST segúna la presencia o no de disfunción ventricular Rev Esp Cardiol 63 2010 915 924
6. C.K. Chow, S. Jolly, P. Rao-Melacini, K.A. Fox, S.S. Anand, and S. Yusuf Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes Circulation 121 2010 750 758
7. F. Schiele, M. Hochadel, M. Tubaro, N. Meneveau, W. Wojakowski, and M. Gierlotka Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction Eur Heart J 31 2010 2614 2624
8. G.K. Andrikopoulos, D.J. Richter, P.E. Dilaveris, A. Pipilis, A. Zaharoulis, and J.E. Gialafos In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study Eur Heart J 22 2001 776 784
9. G. Weisz, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, and G. Guagliumi Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited Am Heart J 150 2005 358 364
10. I. Goldenberg, M. Jonas, A. Tenenbaum, V. Boyko, S. Matetzky, and A. Shotan Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease Arch Intern Med 163 2003 2301 2305
11. R.T. Van Domburg, W.S. Op Reimer, S.E. Hoeks, A.P. Kappetein, and A.J. Bogers Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study Am Heart J 156 2008 473 476
12. J.M. Van Werkhoven, J.D. Schuijf, A.P. Pazhenkottil, B.A. Herzog, J.R. Ghadri, and J.W. Jukema Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography Eur Heart J 32 2011 365 370
13. K. Wilson, N. Gibson, A. Willan, and D. Cook Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies Arch Intern Med 160 2000 939 944
14. S.M. Mohiuddin, A.N. Mooss, C.B. Hunter, T.L. Grollmes, D.A. Cloutier, and D.E. Hilleman Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease Chest 131 2007 446 452
15. J.A. De Velasco, J. Cosín, J.L. López-Sendón, E. De Teresa, M. De Oya, and G. Sellers Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II Rev Esp Cardiol 55 2002 801 809
16. V. Bertomeu, A. Cordero, J. Quiles, P. Mazón, J. Aznar, and H. Bueno Control de los factores de riesgo y tratamiento de la cardiopatía isquémica: registro TRECE Rev Esp Cardiol 62 2009 807 811
17. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyorala, and U. Keil Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
18. Cardiologists should be less passive about smoking cessation. Lancet 2009;373:867.
19. A. Cordero, V. Bertomeu-Martínez, P. Mazón, E. Galve, I. Lekuona, and F. De la Guía Características clínicas y evolución hospitalaria de los pacientes con síndrome coronario agudo en función del tabaquismo Med Clin (Barc) 138 2012 422 428
20. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
21. C.B. Granger, R.J. Goldberg, O. Dabbous, K.S. Pieper, K.A. Eagle, and C.P. Cannon Predictors of hospital mortality in the Global Registry of Acute Coronary Events Arch Intern Med 163 2003 2345 2353
22. E. Núñez, E.W. Steyerberg, and J. Núñez Estrategias para la elaboración de modelos estadísticos de regresión Rev Esp Cardiol 64 2011 501 507
23. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörä lä, U. Keil EUROASPIRE Study Group EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137
24. D.C. Perry, M.I. Dávila-García, C.A. Stockmeier, and K.J. Kellar Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies J Pharmacol Exp Ther 289 1999 1545 1552
25. S. Mottillo, K.B. Filion, P. Belisle, L. Joseph, A. Gervais, and J. O'Loughlin Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials Eur Heart J 30 2009 718 730
26. N.A. Rigotti Clinical practice. Treatment of tobacco use and dependence N Engl J Med 346 2002 506 512
27. H. McRobbie, and S. Thornley La importancia de tratar la dependencia tabáquica Rev Esp Cardiol 61 2008 620 628
28. N.A. Rigotti, A.L. Pipe, N.L. Benowitz, C. Arteaga, D. Garza, and S. Tonstad Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial Circulation 121 2010 221 229
29. T.D. Fraker Jr., S.D. Fihn, R.J. Gibbons, J. Abrams, K. Chatterjee, and J. Daley 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772
30. T.F. Van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A. Erdman, and M.L. Simoons Impact of smoking cessation and smoking interventions in patients with coronary heart disease Eur Heart J 20 1999 1773 1782
31. FDA Drug Safety Communication: Chantix (varenicline) drug label now contains updated efficacy and safety information. Silver Spring: FDA; 2011. Disponible en: http://www.fda.gov/Drugs/DrugSafety/ucm264436.htm